A novel methodology that may eventually be used for testing glaucoma, a leading cause of blindness has been developed. The treatment is expected 10 alleviate the condition through a simple procedure based on an enzyme that does the work of a surgical knife.
Glaucoma afflicts an estimated 2 percent of the world’s adult population and is particularly prevalent among the elderly. The condition occurs when the flow of eye fluid known as aqueous humor is obstructed, ‘Causing an increase in intraocular pressure. This excessive pressure may damage the intraocular portion of the optic nerve, loading to impaired vision and, if untreated to blindness.
There is. No Known cure for glaucoma, but vinous treatments my alleviate the intraocular pressure by either reducing the inflow or increasing the outflow of aqueous humor in the eye. However, the Standard procedures which in clued drugs as the first choice, followed by laser treatment finally conventional surgery Bill have major shortcomings.
: ‘The new technique developed by Prof Arch Yaron and eye Surgeon Dr Jacob Dan of Weizmann i institute is based on the application of a specific enzyme called collagenase Loa small, well-defined arca of the Sclera by means of a specially designed delivery system, This enzyme selectively destroy! Collagen, a pricing that forms the basis of this hand coat of the eye but unlike conventional surge! In which w piece of the sclera is actually cut out and removed, enzyme only thins the layer.
Article extracted from this publication >> September 9, 1994
